Lina Millan, MD
Obstetrics & Gynecology · Watkinsville, GANPI 1578721155
Payments from drug & device makers
What this record shows
This record is dominated by education: $5,513 of the $8,687 with a category attached, or 63.5%. Intuitive Surgical accounts for 67.2% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2022 at $5,181 and has fallen 91.3% since, to $453 in 2025. Among obstetrics & gynecology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 149 payments — averaging $58.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$6K
- AbbVie$723
- Astellas Pharma US Inc$387
- Bayer$231
- Exeltis, USA Inc.$179
- Johnson & Johnson$153
- plus $1K from 25 others
What the payments were for
- Food & beverage$3,17337%
- Education$5,51363%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 15 | $5,836 |
| AbbVie(2 entities) | 32 | $723 |
| Astellas Pharma US Inc | 18 | $387 |
| Bayer | 17 | $231 |
| Exeltis, USA Inc. | 11 | $179 |
| Johnson & Johnson | 2 | $153 |
| Medtronic | 2 | $126 |
| Hologic Sales And Service, LLC | 5 | $117 |
| Aspira Women's Health Inc | 1 | $110 |
| Mayne Pharma Commercial LLC | 6 | $92 |
| Myovant Sciences Inc. | 6 | $92 |
| Sumitomo Pharma America, Inc. | 4 | $89 |
| Boston Scientific | 3 | $71 |
| Therapeuticsmd, Inc. | 3 | $51 |
| Coloplast | 2 | $45 |
| Mylan Pharmaceuticals Inc. | 3 | $42 |
| Agile Therapeutics, Inc. | 3 | $41 |
| Millicent US Inc | 2 | $31 |
| Lupin Inc. | 2 | $30 |
| Axonics, Inc. | 1 | $29 |
| Coopersurgical, Inc. | 1 | $27 |
| Roche Diagnostics Corporation | 1 | $23 |
| Evofem Biosciences, Inc. | 1 | $23 |
| Olympus America Inc. | 1 | $22 |
| Pacira Pharmaceuticals Incorporated | 1 | $20 |
| Organon | 1 | $20 |
| Conmed Corporation | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Baxter Healthcare | 1 | $14 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
| Meditrina | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$5,500
- OVA1$110
- Orilissa$105
How this compares
$8,687 in reported general payments places this provider in the 95th percentile of 1,324 obstetrics & gynecology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 18 | $8,842 |
| GemtesaVibegron | 18 | $8,453 |
| Estradiol | 57 | $2,932 |
| Estradiol (Twice Weekly)Estradiol | 17 | $1,130 |
| Medroxyprogesterone Acetate | 17 | $390 |
| Nystatin | 39 | $316 |
| Clobetasol Propionate | 14 | $247 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 19 | $154 |
| Triamcinolone Acetonide | 32 | $125 |
| Metronidazole | 26 | $119 |
| Ciprofloxacin Hcl | 15 | $54 |
| Misoprostol | 11 | $34 |
| Fluconazole | 11 | $27 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $387 | $8,84218 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $89 | $8,45318 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,324 obstetrics & gynecology providers in Georgia.
Other obstetrics & gynecology in Watkinsville
- Edmund KimLawrenceville$628K
- Jacquelin WaltersDuluth$147K
- Nicole SparksJohns Creek$121K
- Lethenia BakerThomaston$111K
- Renee AllenAtlanta$74K
- Matthew RalstenFayetteville$64K
- Murray FreedmanAugusta$48K
- Tosha Rogers-JonesAtlanta$46K
- Teresa ByrdMarietta$41K
- Christopher BassilSuwanee$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.